Literature DB >> 27114748

Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies.

Susumu Kohno1, Shunsuke Kitajima1, Nobunari Sasaki1, Chiaki Takahashi1.   

Abstract

Carcinogenic transformation of somatic cells resembles nuclear reprogramming toward the generation of pluripotent stem cells. These events share eternal escape from cellular senescence, continuous self-renewal in limited but certain population of cells, and refractoriness to terminal differentiation while maintaining the potential to differentiate into cells of one or multiple lineages. As represented by several oncogenes those appeared to be first keys to pluripotency, carcinogenesis and nuclear reprogramming seem to share a number of core mechanisms. The retinoblastoma tumor suppressor product retinoblastoma (RB) seems to be critically involved in both events in highly complicated manners. However, disentangling such complicated interactions has enabled us to better understand how stem cell strategies are shared by cancer cells. This review covers recent findings on RB functions related to stem cells and stem cell-like behaviors of cancer cells.

Entities:  

Keywords:  Cancer; Cancer stem cells; Retinoblastoma; Stem cells

Year:  2016        PMID: 27114748      PMCID: PMC4835675          DOI: 10.4252/wjsc.v8.i4.170

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  145 in total

Review 1.  Chromatin remodeling and Rb activity.

Authors:  J W Harbour; D C Dean
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

2.  ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.

Authors:  Awad Shamma; Misa Suzuki; Naoyuki Hayashi; Masahiko Kobayashi; Nobunari Sasaki; Takumi Nishiuchi; Yuichiro Doki; Takahiro Okamoto; Susumu Kohno; Hayato Muranaka; Shunsuke Kitajima; Ken-Ichi Yamamoto; Chiaki Takahashi
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

Review 3.  Twists in views on RB functions in cellular signaling, metabolism and stem cells.

Authors:  Chiaki Takahashi; Nobunari Sasaki; Shunsuke Kitajima
Journal:  Cancer Sci       Date:  2012-04-27       Impact factor: 6.716

4.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.

Authors:  R Rubio; I Gutierrez-Aranda; A I Sáez-Castillo; A Labarga; M Rosu-Myles; S Gonzalez-Garcia; M L Toribio; P Menendez; R Rodriguez
Journal:  Oncogene       Date:  2012-12-10       Impact factor: 9.867

Review 6.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

7.  Rb regulates fate choice and lineage commitment in vivo.

Authors:  Eliezer Calo; Jose A Quintero-Estades; Paul S Danielian; Simona Nedelcu; Seth D Berman; Jacqueline A Lees
Journal:  Nature       Date:  2010-08-04       Impact factor: 49.962

8.  Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.

Authors:  Julien Sage; Abigail L Miller; Pedro A Pérez-Mancera; Julianne M Wysocki; Tyler Jacks
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

Review 9.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

10.  A shared role for RBF1 and dCAP-D3 in the regulation of transcription with consequences for innate immunity.

Authors:  Michelle S Longworth; James A Walker; Endre Anderssen; Nam-Sung Moon; Andrew Gladden; Margarete M S Heck; Sridhar Ramaswamy; Nicholas J Dyson
Journal:  PLoS Genet       Date:  2012-04-05       Impact factor: 5.917

View more
  9 in total

1.  The RB-IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity.

Authors:  S Kitajima; A Yoshida; S Kohno; F Li; S Suzuki; N Nagatani; Y Nishimoto; N Sasaki; H Muranaka; Y Wan; T C Thai; N Okahashi; F Matsuda; H Shimizu; T Nishiuchi; Y Suzuki; K Tominaga; N Gotoh; M Suzuki; M E Ewen; D A Barbie; O Hirose; T Tanaka; C Takahashi
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

2.  A tumor suppressor Retinoblastoma1 is essential for embryonic development in the sea urchin.

Authors:  Ana Fernandez-Nicolas; Derek Xu; Mamiko Yajima
Journal:  Dev Dyn       Date:  2019-10-01       Impact factor: 3.780

3.  A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling.

Authors:  H Muranaka; A Hayashi; K Minami; S Kitajima; S Kohno; Y Nishimoto; N Nagatani; M Suzuki; L A N Kulathunga; N Sasaki; N Okada; T Matsuzaka; H Shimano; H Tada; C Takahashi
Journal:  Oncogenesis       Date:  2017-06-26       Impact factor: 7.485

4.  MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6.

Authors:  Akiyo Yoshida; Shunsuke Kitajima; Fengkai Li; Chaoyang Cheng; Yujiro Takegami; Susumu Kohno; Yuan Song Wan; Naoyuki Hayashi; Hayato Muranaka; Yuuki Nishimoto; Naoko Nagatani; Takumi Nishiuchi; Tran C Thai; Sawako Suzuki; Shinji Nakao; Tomoaki Tanaka; Osamu Hirose; David A Barbie; Chiaki Takahashi
Journal:  Oncotarget       Date:  2017-02-21

Review 5.  Beyond What Your Retina Can See: Similarities of Retinoblastoma Function between Plants and Animals, from Developmental Processes to Epigenetic Regulation.

Authors:  Estephania Zluhan-Martínez; Vadim Pérez-Koldenkova; Martha Verónica Ponce-Castañeda; María de la Paz Sánchez; Berenice García-Ponce; Sergio Miguel-Hernández; Elena R Álvarez-Buylla; Adriana Garay-Arroyo
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

Review 6.  Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges.

Authors:  Elizabeth Ford; Jodie Pearlman; Travis Ruan; John Manion; Matthew Waller; Gregory G Neely; Leslie Caron
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

7.  Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells.

Authors:  Eva M Verdugo-Sivianes; Ana M Rojas; Sandra Muñoz-Galván; Daniel Otero-Albiol; Amancio Carnero
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

Review 8.  Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation.

Authors:  Shunsuke Kitajima; Chiaki Takahashi
Journal:  Cancer Sci       Date:  2017-07-29       Impact factor: 6.716

9.  RNA-Sequencing of Primary Retinoblastoma Tumors Provides New Insights and Challenges Into Tumor Development.

Authors:  Sailaja V Elchuri; Swetha Rajasekaran; Wayne O Miles
Journal:  Front Genet       Date:  2018-05-17       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.